Darwin G. Perea-Martínez, Departamento de Medicina, Universidad de Santander, Bucaramanga, Colombia
Byron A. Moreno-Muñoz, Departamento de Medicina, Universidad de Nariño, Pasto, Colombia
Andrea J. Contreras-Ojeda, Departamento de Medicina, Universidad Industrial de Santander, Bucaramanga, Colombia
Juan P. Torres- Romero, Departamento de Medicina, Universidad de Pamplona, Pamplona, Colombia
Edwin A. Gallego-González, Departamento de Medicina, Institución Universitaria Visión de las Américas, Pereira, Colombia
Manuel A. Jaramillo-Acosta, Departamento de Medicina, Universidad del Quindío, Armenia, Colombia
Santiago Gallo-Ramírez, Departamento de Medicina, Universidad de Antioquia, Medellín, Colombia
Michael Ortega-Sierra, Universidad Centroccidental Lisandro Alvarado, Hospital Central Antonio María Pineda, Barquisimeto, Venezuela
Bariatric surgery is an increasingly common surgical procedure, considering its scope and impact on numerous pathological conditions. The frequency of post-intervention complications is a topic of interest in clinical practice. Post-intervention thromboembolic risk is one of the most important considerations during the recovery from bariatric surgery. Various therapies can be used to manage this thromboembolic risk, among which oral direct anticoagulants stand out. Despite the overall effectiveness and safety of this pharmacological group, several authors have raised potential differences to consider in the postoperative scenario of bariatric patients. To date, meta-analyses have only evaluated observational studies to answer this question. Therefore, recognizing the importance of understanding the therapeutic performance of oral direct anticoagulants in one of the increasingly common interventions, the objective of this review is to analyze the performance of oral direct anticoagulants and the risk of thromboembolism after bariatric surgery, based on the most recent evidence.
Keywords: Anticoagulants. Thromboembolism. Bariatric surgery. Risk. Therapeutics.